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ABSTRACT
We describe a versatile genetic system for rapid ana-
lysis of mammalian gene function. In this, loss of
reporter activity in a novel embryonic stem (ES) cell
line enables rapid identification of targeting to the
ubiquitously expressed Rosa26 locus. Subsequent
regulationofgeneactivityisgovernedbyadualregu-
latory strategy utilizing two drugs, Tamoxifen and
Doxycycline. To illustrate this approach, a dominant
allele of Smoothened was introduced into this cell
line, enabling regulated activation of Hedgehog sig-
naling. By coupling Cre-loxP dependent activation
with tetracycline dependent transcription in a single
allele,we establishedaconditionalmethodto control
Smoothenedactivityandneuralprogenitorspecifica-
tion in differentiating ES cells in vitro and in chimeric
embryos in vivo. When crossed to an appropriate Cre
driver strain, gene activity can also be temporally
regulated within a specific cell lineage. This platform
will facilitate rapid analysis of gene function in the
mouse.
INTRODUCTION
The sequencing of the human and mouse genomes along with
high-throughput genomic analyses (i.e. expression proﬁling)
have producedawealthofinformationregardingthe repertoire
of genes associated with a particular biological process and the
hierarchical relationships that exist among these regulatory
factors. The challenge now is to elucidate the functions of
these genes. Transgenic and gene targeting methodologies
have proven to be invaluable approaches for addressing gene
function in the mouse. Further, the ability to modulate gene
activity using conditional genetic manipulation systems, such
as Cre-LoxP mediated DNA recombination and tetracycline
based transcriptional transactivation, have greatly facilitated
the genetic dissection of complex biological questions (1–3).
However, establishing and maintaining genetically engineered
mouse lines are costly, labor intensive and time consuming.
To facilitate the study of complex and multi-staged processes,
such as embryogenesis and tumor formation, a new generation
of genetic systems is required that incorporates spatio-
temporal and reversible gene regulation into a platform that
enables the rapid analysis of gene function in a relevant
biological system.
Here we report an embryonic stem (ES) cell based approach
that combines inducible Cre-loxP mediated activation of gene
transcription and tetracycline-mediated repression to directly
analyze gene function in differentiating ES cells in vitro and
in chimeric embryos derived directly from these cells. Fur-
thermore, this ES cell based system can be easily tailored to
achieve spatio-temporal and reversible gene regulation in the
mouse.
MATERIALS AND METHODS
Generation of ES cell lines
We generated ES cell lines from mice carrying four previously
published alleles. CAGGS-CreER  (4) encodes a ubiquit-
ously expressed, 4OH-tamoxifen regulated fusion protein
between P1 phage integrase Cre and a modiﬁed ligand binding
domain of the human estrogen receptor (5). R26R (6), R26-
EYFP (7) and R26-ECFP (7) encode LacZ, yellow ﬂourescent
protein (YFP) and CFP insertion at the ubiquitously expressed
Rosa26 locus; each allele requires Cre-mediated excision of a
Neomycin phosphotransferase cassette to activate reporter
expression. Blastocysts were obtained from intercrosses
between R26R; CAGGS-CreER males and R26-EYFP or
R26-ECFP females and plated onto mouse embryonic ﬁbro-
blasts (MEFs). These alleles were maintained on a mixed
(C57BL6/J, 129 Sv and Swiss Webster) background. ES
cell lines were generated using standard protocols (8) with
the addition of the MEK1 inhibitor, PD98059 (New England
Biolabs), to the culture media. ES cell lines derived from the
cultured blastocysts were then expanded and frozen down or
genotyped and assayed for speciﬁc reporters at the Rosa26
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doi:10.1093/nar/gni146locus. All genotyping was accomplished by PCR using pri-
mers speciﬁc for CreER, b-gal, YFP and CFP. YFP or CFP
reporters were visualized by epiﬂuorescence microscopy. To
assay for the presence of b-galactosidase, a 35 mm plate of
cells was ﬁxed in formalin/glutaraldehyde for 2 min, and then
subjected to X-gal treatment as described by Whiting et al. (9).
Of the initial EScelllines, three (YFP3,YFP7 and CFP3) were
tested for their ability to contribute to chimeras. Approxim-
ately 50% of embryos recovered from YFP3 cell injection
were highly chimeric. Based on this result, we focused on
this cell line.
Derivation and genetic analysis of the 3-1 cell line
YFP3 cells were cultured in ES cell media supplemented
with 1 mM 4OH-tamoxifen (Sigma) to induce CreER mediated
recombination initially in a single cell suspension, then in
culture for 2–5 days until they had formed relatively large
colonies. Twelve colonies were picked and incubated in
50 ml of trypsin at 37 C for 5–8 min in single wells of a
48-well dish. The trypsinized colonies were triturated in
200 ml of media with 1 mM 4OH-tamoxifen and then trans-
ferred to a single well containing MEFs of a 48-well dish. The
cells were then diluted (1:2) serially in a 48-well dish and
grown for 3–4 days. Wells were assayed for the presence of
the b-gal and YFP reporters and only those colonies that were
positive for expression of the two reporters were propagated
further. Serially diluted wells for these selected subclones
that contained one or at most two colonies were trypsinized
and expanded to three 6 cm dishes and one 3.5 cm dish. The
former was subsequently frozen down for future use and the
latter was subjected to G418 selection. A clonal line, 3–1, that
was YFP
+,b-gal
+ andcompletely sensitive to G418, indicating
complete recombination at each R26R and R26-EYFP allele,
was tested along with the parental YFP3 cells for contribution
to chimeras generated by diploid and tetraploid aggregation
and by blastocyst injection using standard protocols (8).
Rosa26 targeting
We modiﬁed a previously described tetracycline based regu-
latory unit (10) by removing the PGK-Neo and URA selection
cassettes with Cla1 and Xho1 digestion from the original plas-
mid. This modiﬁed unit was then inserted into the Spe1 site 30
ofthe splice acceptor in the pBigT vector (7), generating a new
Rosa26 targeting shuttling vector, pTET-BigT, with multiple
cloning sites (Nhe1, Sal1, Xho1 and Not1) to enable insertion
of cDNAs encoding a gene of interest. cDNAs encoding
dominant regulators of signaling pathways were cloned into
the pTET-BigT vector. The resulting plasmids were digested
with Pac1 and Asc1 to release the Tet-off-ﬂoxed-neo-gene-
of-interest cassettes, which were then inserted into a modiﬁed
Rosa26 targeting vector, pRosa26PAS. pRosa26PAS was
modiﬁed from pRosa26PA (6) by replacing the unique
Kpn1 site in the original vector with a unique Swa1 site to
avoid the likehood of Kpn1 sites in the pTET-BigT and gene-
of-interests. The ﬁnal targeting constructs were linearized and
electroporated into 3-1 ES cells.
After selection in media containing 100 mg/ml G418 for 7–8
days, resistant colonies were picked and transferred to 96-well
plates. After 2–3 days when the majority of ES cells in 96
wells had reached conﬂuence, each well was split into two
96-well plates, one a master plate and the other for ‘color’
screening to identify probable targeting events at the Rosa26
locus. On the screening plate, positive targeting events were
ﬁrst scored for loss of YFP under the ﬂuorescence microscope,
followed by b-galactosidase staining to identify lacZ negative





+ depending on which Rosa26
allele underwent homologous recombination), these colonies
were expended on the master plate and frozen for future
analysis.
In vitro ES cell analysis, immunocytochemistry and
western blot
The targeted 3-1 ES cells were grown on a gelatin-coated
4-well chamber slide. 4OH-tamoxifen (1 mg/ml) (Sigma)
and Doxycycline (1 mg/ml) (Sigma) were added into culture
media at different time points. After 2–5 days, the cells were
ﬁxed in 4% paraformaldehyde for 30 min at 4 C for sub-
sequent immunostaining, or harvested, lysed, and proteins
were separated by SDS–PAGE prior to western blot analysis
using an anti-GFP antibody (AB293, ABcam), 1:5000.
The embryoid body (EB) differentiation assay was per-
formed as described previously (11). Two days after EB
formation, medium was replaced and supplemented with ret-
inoic acid (RA) (500 nM) (Sigma) and 4OH-tamoxifen
(1 mg/ml) (Sigma), and EBs were cultured for an additional
3–5 days. EBs were then ﬁxed, sectioned and processed
for immunoﬂuoresence staining as described previously (11).
The following antibodies were used in this study: rabbit
anti-GFP 1:1000 (AB293, Abcam), mouse anti-Nkx2.2 1:30
(Developmental Studies Hybridoma Bank), mouse anti-
FoxA2 1:20 (Developmental Studies Hybridoma Bank),
mouse anti-MNR2 1:300 (Developmental Studies Hybridoma
Bank) and rat anti b-galactosidase 1:500 (Biogenesis).
Generation of R26T-SmoM2 chimeras
The targeted R26T-SmoM2 ES cells (YFP
 ;LacZ
+) were
injected into host (C57BL6J, Jackson Laboratories) blasto-
cysts. The blastocysts were transferred into the uterus of
pseudopregnant hosts (Swiss Webster, Taconic) at E2.5.
Embryos were collected at E10.5 and E13.5 after administra-
tion of Tamoxifen (Sigma) at a single dose of either 4 mg/40 g
or 2 mg/40 g body weight by intraperatoneal injection
into the pregnant dam at E8.5. Chimerism was assessed by
whole mount b-galactosidase staining as described (9). For
tetracycline-mediated regulation, one day prior to embryo
transfer pseudopregnant dams were administrated 200 ml
of Doxycycline (10 mg/ml) by oral gavage. In addition,
the drinking water was supplemented with 1 mg/ml of
Doxycycline to maintain silencing of tTA driven regulatory
cassettes.
Generation of a R26T-SmoM2 line and neural
crest-specific activation of Hh signaling
The targeted R26T-SmoM2 3-1 ES cells (YFP
 ;LacZ
+) were
injected into C57BL6J blastocysts to generate chimeras.
b-Galactosidase staining performed on tail and ear biopsies
taken from chimeras was used to assess chimerism. The
CAGGS-CreER transgene was segregated from the R26T-
SmoM2 line after germline transmission. Wnt1-Cre has
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embryos were obtained from the crosses of Wnt1-Cre females
and R26T-SmoM2 males.
RESULTS
Generation of the 3-1 ES cell line
The general strategy we have adopted is outlined in Figure 1.
Since its identiﬁcation as a ubiquitously expressed locus that
enables position independent expression of a gene of interest,
targeting at the Rosa26 locus has become a common strategy
for the general widespread tissue independent expression of a
gene under study. To simplify and speed up the analysis of
successful targeting events at this locus, we envisioned a
scheme where each Rosa26 allele ubiquitously expressed a
reporter whose loss as a result of homologous recombination
at that locus could be readily assayed. For example, if one
allele expresses the Escherichia coli lacZ gene, and the other a
YFP encoding gene, a simple histochemical staining proced-
ure for b-galactosidase production or direct visualization of
YFP ﬂuorescence enables the ready identiﬁcation of targeting
at either allele. Further, the remaining constitutively expressed
marker enables ES cells and their derivatives to be visualized
in chimeric progeny.
In the next step, we wanted to control the expression of a
gene introduced into the Rosa26 locus. Previous studies
from our group have described a transgenic mouse line,
CAGGS-CreER,which ubiquitouslyexpresses a CreER fusion
protein (4). In this transgene line, recombination catalyzed
by the P1 integrase, Cre, at its target LoxP recognition
sites, is Tamoxifen dependent, enabling drug-dependent con-
trol of Cre-mediated DNA recombination. In an ES cell
line that expresses the CreER transgene, this enables a simple
genetic switch to control gene expression at the Rosa26 locus
in ES cells and their differentiated descendents (Figure 1).
When a gene, X, is targeted into the Rosa26 locus with a
LoxP-ﬂanked gene cassette (pGKNEO in Figure 1) positioned
to block transcription of gene X, addition of 4OH-tamoxifen
in vitro or Tamoxifen in vivo will result in the excision of
this cassette initiating gene X transcription thereby enabling
the function of this gene to be explored in ES cells and their
differentiated derivatives in culture, in chimeric embryos and
in adult mice that are derived directly from targeted ES cells
(Figure 1).
In the ﬁrst step towards the generation of the desired ES cell
system, we generated a male ES cell line, YFP3, which carried
the CAGGS-CreER transgene and previously described LacZ
and YFP reporter alleles at each Rosa26 locus (6,7). These
reporter alleles are themselves silent until Cre-mediated
removal of a LoxP-ﬂanked neomycin phosphotransferase
positive selection cassette introduced in the original gene
targeting events. Only occasional, sporadic expression of
the reporters was observed either in vitro in ES cell culture
or in vivo in ES cell derived chimeras, in the absence of drug
(data not shown). In contrast, the addition of 4OH-tamoxifen
to ES cell culture and Tamoxifen injection into pregnant dams
at E8.5 lead to a robust induction of reporters in the ES cell
line (Figure 2A and B) and in chimeric embryos assayed at
E10.5 (Figure 2C and D). These analyses, and others, veriﬁed
the genetic identity of the YFP3 cell line, validated the drug
induced genetic switch and demonstrated the ability of the ES
cell line to contribute widely to embryonic and adult tissues
including the male germline (data not shown).
Figure 1. 3-1 ES cells and rapid functional analysis in vitro and in vivo.
(A) Schematic representation of targeting the Rosa26 locus in 3-1 ES cells.
YFPandb-galare expressedundertheendogenousRosa26promoterin3-1ES
cells that also possess a CAGGS-CreER transgene. When a gene of interest is
targeted into Rosa26 locus, positive colonies can be screened by loss of either
YFP or b-gal expression. (B) Functional analysis on ES cells or G0 chimeric
embryos derived from 3-1 ES cells.
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dilution in the presence of 4OH-tamoxifen (Materials and
Methods) to isolated a clonal line that excised the neomycin
phosphotransferase cassettes at both the R26-EYFP and R26R
alleles; such a line would be G418 sensitive, YFP
+ and
b-galactosidase
+. We identiﬁed a clonal line, 3-1, which met
all three criteria. Chimeric analysis demonstrated that 3-1 cells
show similar high-level chimerism and germline competence
as the parental YFP3 cells. Further, analysis in chimeras gen-
erated with tetraploid embryos demonstrated that 3-1 cells are
able to generate late gestational stage embryos that are wholly
3-1 ES cell derived (data not shown).
Cre-LoxP and tetracycline-mediated reversible
gene expression in 3-1 ES cells
While the 3-1 cell system in principle provides a rapid strategy
for introducing genes into the Rosa26 locus and enable expres-
sion at the locus to be drug regulated, once a gene is activated
by a Cre-mediated recombination event, expression is per-
manent. To improve the spatio-temporal regulation, we next
combined the Cre-LoxP system with tetracycline regulation
(Figure 3). To this end, we engineered a modiﬁed Rosa26
knock-in vector. This contains a LoxP-ﬂanked selection and
transcriptional stop cassette that enables positive selection for
vector integration and transcriptional silencing of a down-
stream gene of interest, preceded by a tetracycline regulatory
unit. In this, a cDNA sequence encoding the Doxycycline
(Dox) controlled transactivator (tTA) is coupled with a min-
imal CMV promoter and the tet operator sequence (TetO) (10).
In theory, when integrated into the Rosa26 locus, the tTA
proteins are expressed under the ubiquitously expressed,
constitutive Rosa26 promoter, but the LoxP- ﬂanked stop
cassette will render a gene of interest transcriptionally silent
(Figure 3A). However, on Cre-mediated recombination, tTA-
mediated transcriptional activation is initiated (Figure 3B).
This situation is also reversible; on addition of Doxycycline,
tTA binds to the drug, and the gene of interest is transcrip-
tionally silenced (Figure 3C).
As a proof of principle of this approach, we targeted a
dominant activator of the Hh pathway, SmoM2, into the
Rosa26 locus of 3-1 ES cells with dual Cre-LoxP and
tetracycline-mediated regulation (Figure 3D). Smoothened
is a 7 pass membrance protein and key component of the Hh
pathway essential for the transmission of a Hh signal in all Hh
responsive cells. Smo-M2 was originally identiﬁed as a point
mutation, W539L, within the seventh transmembrane domain
thatleadstoconstitutive,high-level,ligandindependentactiva-
tion of Hedgehog signaling in responsive cells (12). To dir-
ectly visualize SmoM2 in targeted cells, we generated a fusion
protein, SmoM2-YFP, with YFP fused to the C-terminus of
SmoM2 such that SmoM2 activity was not modiﬁed.
We electroporated the drug regulated SmoM2 targeting
construct into the 3-1 ES cells and screened for colonies
that had lost YFP or LacZ expression (see strategy in
Figure 1). In general, 10–15% of the G418 resistant colonies
were identiﬁed by this color screen. Since the color screen can
be readily completed in the ﬁrst passage after picking G418
resistant colonies, it avoids the frequent freezing and thawing
of ES cells and Southern analysis normally required for
Figure 3. Cre-LoxP and tetracycline dependent gene expression in Rosa26 locus. The native Rosa26 promoter drives expression of the tetracycline transactivator
(tTA)thatinducestranscriptionofthegeneofinterestafterCre-mediatedremovalofthePGK-Neo-4XpAcassette(AandB).(C)Doxycycline(opencircles)bindsto
tTA proteins (black bar), which undergo conformational change and dissociate from tetO, resulting in termination of transcription. (D) Schematic representation of
the R26T-SmoM2 allele.
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time-consuming steps can be removed from the
procedure.
The presence of CAGGS-CreER in 3-1 ES cells also
enabled rapid in vitro analysis of the induction of
SmoM2-YFP, and importantly the testing of activation and
Doxycycline-mediated repression of SmoM2-YFP in targeted
ES cells and their derivatives. We selected a YFP
 , LacZ
+ cell
line and examined induction and repression of SmoM2-YFP
by immunocytochemistry and western blot following 4OH-
tamoxifen and Doxycycline treatment. In the absence of
Doxycycline and 4OH-tamoxifen, expression of SmoM2-
YFPwas rarelyobserved(Figure 4A).Incontrast,supplement-
ing the culture media with 1 mg/ml of 4OH-tamoxifen lead to
synthesis of a membrane localized SmoM2-YFP fusion pro-
tein in most ES cells with 2 days of culture (Figure 4A).
Western blot analysis conﬁrmed the 4OH-tamoxifen depend-
ent induction of SmoM2-YFP (Figure 4B). On addition
of 1 mg/ml of Doxycycline, expression was inhibited by
Doxycycline and inhibition was reversible following Doxy-
cycline removal (Figure 4C). These results demonstrate that
gene expression at the Rosa26 locus is, as expected, dependent
on an initial 4OH-tamoxifen triggered recombination event.
However, as the resulting expression is itself tTA dependent,
the transcription of the targeted gene at the Rosa26 locus
can be controlled after Cre recombination by Doxycycline
administration.
In vitro functional analyses of R26T-SmoM2 3-1
ES cells
To evaluate the utility of the 3-1 ES cell line as a tool to study
gene function in vitro, we generated neural precursors from
EBs derived from R26T-SmoM2 3-1 ES cells (11). The EBs
were treated with RA to caudalize neural progenitor cells,
and 4OH-tamoxifen to activate expression of SmoM2 thereby
initiating Hh signaling. Induction of FoxA2 in the ﬂoor plate
and Nkx2.2 in pV3 interneuron progenitors occurs as a direct
response to Shh signaling and requires Smo activity (13,14).
Joint exposure of EBs to RA and 4OH-tamoxifen induced a
large number of Nkx2.2
+ (pV3 interneuron progenitor marker)
and FoxA2
+ (ﬂoor plate marker) cells neither of which were
present in untreated controls (Figure 5A and B). The robust
induction of the two most ventral progenitor markers indicates
high-level Hh signaling in SmoM2 expressing cells as these
two populations require the highest levels of Hh signaling
input for their normal speciﬁcation in the developing neural
tube (13).
To further determine if motor neurons are also generated
in the R26T-SmoM2 3-1 ES cell derived EBs, we analyzed
the expression of MNR2, a transcription factor speciﬁcally
expressed by mature motor neurons (15). RA exposure
alone failed to efﬁciently induce MNR2expression, but expos-
ure of RA-treated EBs to 4OH-tamoxifen for 5 days generated
MNR2
+ neurons in a subset of SmoM2 expressing cells and
neighboring cells, most probably the result of induction of Shh
itself in response to SmoM2-YFP activation (Figure 5C).
MNR2
+ cells that were SmoM2-YFP
+ generally exhibited
low levels of SmoM2-YFP expression, in contrast to the
high levels of SmoM2-YFP routinely present in FoxA2
+ or
Nkx2.2
+ cells, presumably a reﬂection of the variable onset
of recombination during the extended culture period.
We next examined Doxycycline-mediated repression of
SmoM2-YFP in EBs generated from R26T-SmoM2 3-1 ES
cells. In culture media containing 4OH-tamoxifen, RA and
Doxycycline (1 mg/ml), no evidence of motor neuron, pV3
or ﬂoor plate speciﬁcation was observed (Figure 5A–C). Thus,
SmoM2 expression was tightly regulated by Doxycycline
during the in vitro differentiation of EB derived neural
progenitors.
G0 chimeric functional analysis using 3-1 ES cells
To test the utility of the R26T-SmoM2 3-1 ES cells for rapid
functional analysis in vivo, we generated G0 chimeric embryos
by either blastocyst injection or morula aggregation, and dir-
ectly analyzed G0 progeny. Tamoxifen (4 mg/40 g body
weight) was injected intraperitoneally at E8.5 into pregnant
recipients, and embryos were collected 48 h post-injection. In
the neural tube of high contribution chimeras, assessed by
the production of E.coli b-galactosidase from the ROSA26
allele that was not targeted by the SmoM2-YFP insertion




+ ventral cell fates following Tamoxifen
injection (Figure 6A and data not shown). In contrast, highly
chimeric embryos isolated from recipients treated with 200 ml
of 10 mg/ml Doxycycline by oral gavage the day before
surgical transplantation and maintained on Doxycycline sup-
plemented drinking water (1 mg/ml) thereafter, showed
an entirely normal neural tube pattern following Tamoxifen
injection (Figure 6A).
When chimericembryos were examined atE13.5, following
a lower dose Tamoxifen injection at E8.5 (2 mg/40 g body
weight), embryos displayed phenotypes typical of gain-of-
function in Hh signaling, such as dorsal CNS hyperprolifera-
tion and polydactyly, that were not observed in chimeras from
recipients maintained on Doxycycline (Figure 6B). Thus, the
dual regulatory system allows drug-mediated control of gene
activity in vivo as predicted.
Figure 4. Regulation of SmoM2-YFP expression in 3-1 ES cells. The expres-
sion of SmoM2-YFP in targeted 3-1 ES cells was induced by 1 mg/ml of
4OH-tamoxifen, as shown by immunostaining (A) and western blot (B).
(C) Doxycycline controls SmoM2-YFP expression in ES cells. In the presence
of1mg/mlofDoxycycline,4OH-tamoxifen(1mg/ml)failedtoinduceSmoM2-
YFP expression. SmoM2-YFP was expressed after removal of Doxycycline.
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through a R26T-SmoM2 allele
In addition to enabling rapid functional G0 analysis, the regu-
latory scheme we describe can be coupled with any existing
Cre line for a cell-type speciﬁc G1 study. Here, Doxycycline
control enables expression of the gene of interest to be tem-
porally regulated within a particular cell lineage following
the initial recombination event. To demonstrate the utility
of the 3-1 ES cell system with cell-type speciﬁc Cre lines,
we established a germline R26T-SmoM2 mouse strain. These
mice were crossed with a Wnt1-Cre transgene, a cross that is
expected to drive widespread expression of SmoM2 through-
out the neural crest lineage as well as in much of the dorsal
neural tube (5). Consistent with a previous report (16), ectopic
Hh signaling in the Wnt1-Cre and R26T-SmoM2 embryos
resulted in a severe dorsal CNS overgrowth and defective
development of neural crest cells arising from this region,
one result of which was a gross dysmorphology within the
frontal-nasal processes. These phenotypes were completely
suppressed in embryos isolated from dams maintained on
Doxycycline supplemented drinking water, validating the
temporal suppression of SmoM2-YFP activity (Figure 7).
Spatio-temporal regulation of major signaling pathways
Having demonstrated the utility of the 3-1 ES cells in provid-
ing a rapid and robust means to target the Rosa26 locus and
having tested the feasibility of dual regulatory drug control in
regulationoftargetedallelebymanipulating Hhsignalingwith
a SmoM2-YFP allele, we envisioned the establishment of a
suite of similarly designed ES cells that enable the manipula-
tion of each of ﬁve major developmental signaling pathways
(Hedgehog, Wnt, BMP, FGF and Notch) to aid in the genetic
dissection of complex processes in vitro and in vivo. Towards
this long term goal we have established Cre-LoxP and Doxy-
cycline regulated ES cell lines with ROSA26 knock-ins of
a dominant active allele of b-catenin, a dominant negative
mutant of FGFR2 and a Noggin-CD4-GFP fusion to modulate
canonical Wnt, FGFor BMP2/4 signaling, respectively. The
construction of other cell lines are in progress.
DISCUSSION
We report and validate a novel ES cell based system that
couples the advantages of position independent transcriptional
regulation with drug-mediated control of gene activity. This
Figure 5. Directed neural differentiation in EBs derived from 3-1 ES cells. (A) EBs grown for 3 days with RA but not tamoxifen did not contain FoxA2 progenitor
cells.EBsgrownfor3dayswithbothRAandTamoxifencontainedmanyFoxA2cells,whichalsoexpressedhighlevelsofSmoM2-YFP.EBsgrownfor3dayswith
RA,4OH-tamoxifenandDoxycyclinedidnotexpressSmoM2-YFPanddidnotcontainFoxA2cells.(B)CoexpressionofSmoM2-YFPandNkx2.2intheEBsgrown
for3 dayswithRAand 4OH-tamoxifen,butnotDoxycycline. (C) CoexpressionofSmoM2-YFP andMNR2ina subsetofSmoM2-YFP expressingcells in the EBs
grown for 5 days with RA and 4OH-tamoxifen.
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for the dissection of signaling pathway activities in ES cells
in vitro and in the developing and adult mouse, complement
the growing genetic resources for the mouse model. Given the
current interest in directing differentiation of ES cells in vitro
towards speciﬁc cell types of clinical relevance, the 3-1 ES
cell system will facilitate the rapid dissection of regulatory
mechanisms and enable the potential genetic screening of
regulatory components. Further, the ability to move from
tissue culture to direct analysis of G0 animals is a signiﬁcant
advantage offered by the strategy we describe, especially
considering two key drawbacks of the mouse system; time
in breeding strains and cost in their subsequent maintenance.
To date, there have been several reports of inducible
Cre-mediated recombination systems in ES cells that enable
the temporal induction of gene activity (17,18). Here we fur-
ther optimized gene expression at the Rosa26 locus with a
reversible spatio–temporal regulation. Several tetracycline
(tTA or rtTA) based ES cell systems have also been developed
(19–23). The requirement for multiple components and/or
the lack of spatial and lineage-speciﬁc regulation limit their
general utility for certain in vivo studies. By coupling Cre
Figure 6. FunctionalanalysisofG0chimericembryosderivedfromR26T-SmoM23-1EScells.(A)EctopicdorsalexpansionofventralmarkersNkx2.2andFoxA2
in theneuraltubeofchimeraswithhighEScell contribution atE10.5aftertamoxifeninjectionat E8.5.(B) Hhsignalinggain-of-function phenotypessuch asdorsal
CNS hyperproliferation and polydactyly on highly chimeric embryos at E13.5 after tamoxifen injection at E8.5. (A and B) No phenotype was observed on the high
contribution embryos with Doxycycline treatment.
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single locus, we are able to utilize the growing resources of
cell-type speciﬁc Cre strains for functional analyses within
speciﬁc cell or tissue types with the added advantage of
temporal control of gene activity within descendants of a
speciﬁc lineage. While this paper was in preparation, a
similar dual regulatory strategy based on rtTA dependent,
Doxycycline-mediated activation of a gene of interest follow-
ing a Cre-excision event was reported (24). Our Doxycycline
based repression system with the advantage of the 3-1 ES cell
line provides a complementary approach. The utility of this
system has been demonstrated here using the example of a
Hh signaling component having well-understood and pre-
dictable phenotypes to provide a rigorous validation of the
model. The cell autonomous manipulation of dominant
active or dominant negative forms of key members of the
signaling pathways is probable to be widely applicable to
the analysis of development and the understanding and treat-
ment of diseases. For example, increasing evidence links
Hedgehog, Wnt, Notch and BMP signaling pathways to the
regulation of stem cell biology and tumor formation (25,26).
The cellular and genetic tools we describe will facilitate the
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